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ABSTRACT
Mms19 encodes a cytosolic iron-sulphur assembly component. We
found that Drosophila Mms19 is also essential for mitotic divisions
and for the proliferation of diploid cells. Reduced Mms19 activity
causes severe mitotic defects in spindle dynamics and chromosome
segregation, and loss of zygotic Mms19 prevents the formation of
imaginal discs. The lack of mitotic tissue in Mms19P/P larvae can be
rescued by overexpression of the Cdk-activating kinase (CAK)
complex, an activator of mitotic Cdk1, suggesting that Mms19
functions in mitosis to allow CAK (Cdk7/Cyclin H/Mat1) to become
fully active as a Cdk1-activating kinase. When bound to Xpd and
TFIIH, the CAK subunit Cdk7 phosphorylates transcriptional targets
and not cell cycle Cdks. In contrast, free CAK phosphorylates and
activates Cdk1. Physical and genetic interaction studies between
Mms19 and Xpd suggest that their interaction prevents Xpd from
binding to the CAK complex. Xpd bound to Mms19 therefore frees
CAK complexes, allowing them to phosphorylate Cdk1 and facilitating
progression to metaphase. The structural basis for the competitive
interaction with Xpd seems to be the binding of Mms19, core TFIIH
and CAK to neighbouring or overlapping regions of Xpd.
KEY WORDS: Mitotic gene, Mms19, Xpd, Cdk-activating kinase,
Drosophila development
INTRODUCTION
Considering the countless insults that DNA and chromosomes have
to sustain, it is amazing how faithfully the genome is duplicated and
passed on to daughter cells during mitosis. mms19 was first
identified in Saccharomyces cerevisiae as a gene that is necessary
for repairing alkylated DNA and for the removal of ultraviolet light-
induced pyrimidine dimers by the nucleotide excision repair (NER)
pathway (Prakash and Prakash, 1977, 1979). Extracts from yeast
cells mutant for mms19 showed impaired RNA polymerase II
transcription, a defect that could be corrected by the addition of the
TFIIH transcription complexes to the extract, but not by purified
Mms19 (Lauder et al., 1996). Reduction of MMS19 activity in
higher eukaryotes causes additional phenotypes such as defective
mitotic spindles and chromosome segregation defects, extended
telomeres and defects in methionine synthesis (Askree et al., 2004;
Ito et al., 2010; Lauder et al., 1996). From this, it appears that
MMS19 might have diverse functions in eukaryotes.
MMS19 physically interacts with proteins of the cytoplasmic
iron-sulphur cluster (Fe-S) assembly complex, such as Ciao1, IOP1
(NARFL), MIP18 (FAM96B) (Gari et al., 2012; Stehling et al.,
2012; Ito et al., 2010). Additionally, immunopurification of human
cytoplasmic complexes containing MMS19 led to the identification
of 12 known Fe-S proteins, including XPD (ERCC2), RTEL1
(regulator of telomere length protein), FANCJ (Fanconi anemia
protein J; also known as BRIP1), DNA Polymerase δ, and Pri2, as
its interacting proteins (Gari et al., 2012; Stehling et al., 2012). The
functional significance of these interactions were addressed in yeast,
where the absence ofMms19 caused a significant reduction of 55Fe
incorporation into human XPD, which was overexpressed as a Fe-S
cluster target protein. Similarly, 55Fe incorporation into other Fe-S
cluster proteins, including Leu1, Ntg2 and Rli1, was also found to
requireMms19 (Gari et al., 2012; Stehling et al., 2012). When these
target proteins did not obtain the Fe-S clusters, they displayed
reduced activity and decreased protein stability. In contrast, at least
in HeLa cells, knockdown of MMS19 did not affect the activity or
levels of two other known Fe-S proteins, IRP1 (iron regulatory
protein 1; also known as ACO1) and GPAT (glutamine
phosphoribosylpyrophosphate amido transferase; also known as
PPAT) (Stehling et al., 2012). From these results it was concluded
that MMS19 is involved in the assembly of Fe-S clusters of only a
subset of proteins that contain such clusters. For this subset of Fe-S
cluster-containing proteins, proper expression of MMS19 is
necessary for stability and protein activity. Under normal MMS19
expression, the association of the target protein with the cytoplasmic
iron-sulphur assembly (CIA) targeting complex is transient and the
protein remains an apoform until the Fe-S cluster is incorporated.
But in the absence of MMS19 this interaction becomes more stable
as the target protein awaits the incorporation of Fe-S (Gari et al.,
2012). Combined, the studies described above in yeast and human
cells highlight the role MMS19 plays as part of the CIA machinery
in the maturation of a subset of Fe-S-containing proteins. It
contributes to their activation and indirectly affects the downstream
enzymatic functions of these target proteins.
Ito et al. observed that reducingMMS19 levels inHCT116 cells and
HeLa cells strongly increased the formation of abnormal mitotic
spindles (Ito et al., 2010). Aside from multipolar and monopolar
spindles, chromosome segregation abnormalities increased strongly,
too. This study pointed for the first time to a mitosis-specific role for
MMS19 and possibly the entire MMXD complex (MMS19/MIP18/
XPD). What the physiological role of this function could be and
whether the mitotic defects reflect the role of MMS19 in the CIA
machinery or a more direct MMS19 function in mitosis remained
unknown. We set out to address this question in the Drosophila
melanogastermodel system, in which it is possible to test for mitosis-
specific functions that are not dependent on the transcriptional
function of the test gene. Here, we demonstrate that the mitoticReceived 1 July 2017; Accepted 18 December 2017
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function of Mms19 is essential for normal diploid cell cycles, organ
growth and development. We further show that Mms19 not only has
an activating role towards Xpd, but that it also functions to prevent
Xpd from repressing the Cdk-activating kinase function of Cdk7
duringmitosis.Mms19 thus allowsCdk7 to produce the high levels of
active mitotic Cdk1 kinase that are required for cells to proceed
through the first phase of mitosis.
RESULTS
Mms19 is an essential gene highly expressed in ovaries,
embryos and diploid larval tissue
The Mms19P allele causes lethality when homozygous or
hemizygous over an unrelated deficiency (Df) chromosome. This
P-element, inserted into the third exon of Mms19, disrupts the
production of normal Mms19 mRNA (Fig. S1). To study Mms19
expression and Mms19 protein distribution at normal expression
levels, we generated a transgenic fly line expressing Mms19 C-
terminally fused to eGFP from its predicted endogenous genomic
control sequences. One copy of the Mms19::eGFP transgene was
sufficient to fully rescue the lethality of the Mms19P chromosome
over an unrelated Df chromosome that removes Mms19 (Table 1).
This shows that the Mms19::eGFP fusion protein is functional. The
fact that two copies of Mms19::eGFP rescue less efficiently might
point to an unknown recessive second site hit on the chromosome
that carries the transgene. We also performed these rescue
experiments with homozygous Mms19P/P animals (Fig. S2A).
Again, we observed an efficient rescue of the lethality, even though
the rescuewas not 100%. This reduction might, however, point to the
presence of a recessive second site hit on the Mms19P chromosome.
FlyBase data (flybase.org) from independent projects showelevated
expression of Mms19 mRNA in young embryos, ovaries and testes,
imaginal discs, and moderate expression in some other tissues and
parts such as the larval CNS, salivary glands, guts and carcasses. We
used the Mms19::eGFP line in the Mms19P/P background to confirm
the expression of Mms19 in young embryos, ovaries and different
tissues of third instar larvae, including brains and imaginal discs
(Fig. S2B).
Mms19P phenotype points to essential mitotic functions in
diploid cells
Mms19P/P mutants survive embryonic development possibly
because of their maternal supply of functional Mms19. Mms19P/P
larvae develop slowly, but reach the third instar stage. However, in
contrast to wild-type larvae, mutants do not contain recognizable
imaginal discs (compare Fig. 1A-A″ with B-B″) and they do not
pupate. Imaginal discs are patches of cells put aside during larval
stages to give rise to adult structures during pupation. These cells are
diploid and undergo numerous mitotic division cycles during larval
development. In contrast, large parts of the larval tissue consist of
polyploid cells that have become polyploid through repeated DNA
synthesis (S phase) in the absence of intervening M phases and cell
divisions. These large cells with their highly polyploid nuclei are then
resorbed during the pupal stage. Interestingly, these polyploid cells
appear normal at the phenotypic level, indicating that they are less
dependent onMms19.This phenotype of theMms19mutant is typical
for genes involved in mitotic proliferation (Gatti and Baker, 1989).
Loss of maternalMms19 causes cell cycle defects in young
embryos
To study the loss-of-function phenotype ofMms19 duringmitosis, we
induced homozygousMms19P/P germline clones in females using the
FRT system combined with ovoD, which eliminates wild-type
germline cells (Chou and Perrimon, 1996). With this tool, all eggs
laid will be derived from a germline that was homozygous mutant for
Mms19P, and young embryos derived from these eggs do not obtain
wild-typeMms19 protein during the early stages of development until
the zygotic genes are activated. Upon fertilization by Mms19+/+
fathers, 24.5% of the embryos hatched as larvae whereas upon
fertilization with heterozygous Mms19P/+ males only 10.5% hatched
as larvae (Fig. S3). Furthermore, the maternal effect lethality could be
rescued to 66.5% with two maternal copies of Mms19::eGFP. This
indicates thatmaternalMms19 is essential forembryonicdevelopment,
but about a quarter of the embryos can be rescued by one copy of
zygotic Mms19 (1 in 4 if they all receive a wild-type copy from their
fathers and 1 in 8 if half of the embryos receive a wild-type copy).
Young Drosophila embryos develop in a syncytium of rapidly
dividing nuclei. Confocal microscopy analysis of the syncytial
division cycles of embryos derived from Mms19P eggs and
heterozygous fathers revealed important mitotic functions for
Mms19 (Fig. 2). About half of the embryos reached division cycles
10-13, when cell cycle features are best visible. About 60% of these
embryos showed various cell cycle defects (n=260), which we
classified into six phenotypic classes: spindle defects, kinked axis of
division, many missing nuclei, elongated spindle in metaphase,
chromosome segregation defects, and centrosomal defects (Fig. 2).
The expression ofMms19::eGFP in theMms19P/P germline mutants
rescued the defects of all six phenotypic classes at least partially,
and only 20% of these embryos showed one or more of the defects
in division cycle 10-13. Clearly, maternal Mms19 is important for
proper progression through mitosis in young embryos.
Knockdown of Mms19::eGFP protein causes cell cycle
defects and chromosomal abnormalities in young embryos
The defects observed in young embryos derived from Mms19P/P
germline clones could either reflect a direct function of Mms19 in
the embryo or it could be a more indirect consequence of the
absence of Mms19 during oogenesis. To test whether Mms19 is
indeed required during embryogenesis, we decided to knock down
the Mms19 protein specifically in young embryos. For this purpose,
we first rescued the lethality and sterility of the Mms19P/P mutants
with the already-described Mms19::eGFP construct under its
endogenous promoter. We then knocked down the Mms19::eGFP
protein (in the Mms19P/P background) using the anti-GFP
nanobody-based deGradFP technique (Caussinus et al., 2012). To
knock down the GFP fusion protein only in young embryos and not
during oogenesis, the deGradFP construct was expressed under the
control of the maternal hunchback (hb) promoter coupled with the
Table 1. Frequency of expected and observed eclosed flies in the F1
offspring of w; Mms19::eGFP/SM1; Mms19P/TM3 Sb × w; Mms19::
eGFP/SM1; Df(3R)ED5147/TM3 Sb
Mms19::eGFP
copies* Genotype‡
Expected
frequency (%)
Observed
frequency (%)
1 Mms19P or Df/TM3 Sb 44.4 46.9
1 Mms19P/Df 22.2 24.8
2 Mms19P or Df/TM3 Sb 22.2 17.3
2 Mms19P/Df 11.1 10.9
*Number of Mms19::eGFP alleles on the second chromosomes of the
offspring (2: homozygous; 1: heterozygous transgene over SM1 balancer).
‡Offspring genotype of the third chromosome.
Note that SM1/SM1 and TM3 Sb/TM3 Sb are lethal.
n=831.
w; Mms19::eGFP/SM1; Mms19P/TM3 Sb x w; Mms19::eGFP/SM1;
Df(3R)ED5147/TM3 Sb.
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bcd 3′UTR element that represses its translation during oogenesis
until egg activation (P.V.-P., unpublished). Relative to the tubulin
standard, only low levels of deGradFP are expressed in ovaries
compared with embryos and, importantly, the Mms19::eGFP signal
is not reduced in ovaries when comparing flies that have the
deGradFP gene with those that do not carry it (Fig. S4). This is in
contrast to the embryonic extracts, in which the presence of the
deGradFP caused a clear reduction of the Mms19::eGFP signal
relative to the loading control.
Expressed maternally in young embryos, the deGradFP system
does indeed reduce Mms19::eGFP levels to less than 50% (Fig. S4;
for quantification see also Fig. 5G). To study the effect of the
knockdown in young embryos at the cellular level, we also used
control embryos that expressed the Mms19::eGFP fusion construct
and the deGradFP construct, but in addition contained an
endogenous wild-type allele of Mms19 (Fig. 3A-A‴). This
controls for dominant effects that might be caused by degrading
Mms19::eGFP by the deGradFP technique. Accordingly, we expect
such control embryos to display background levels of defects that are
as high as or higher than those of a true wild-type strain. Indeed, the
deGradFP itself produced a slight increase in mitotic defects
(Fig. 3H). As opposed to these control knockdowns, experimental
knockdown of the fusion protein led to various and abundant cell
cycle defects, which we classified into five phenotypic groups.
Twenty-five percent of the embryos showed improper chromosome
segregation and chromosomal bridges (Fig. 3H), which was evident
in anaphase and telophase of the cell cycle (Fig. 3B). The mitotic
spindles of mutant embryos fixed in metaphase of cycle 10 were
consistently longer than control spindles (compare Fig. 3Cwith 3D).
Apart from this, we observed higher frequencies of defects in spindle
formation and dynamics (Fig. 3E), including spindle crossovers,
multipolar spindles and kinked axis of division (Fig. 3F). In these
cases, centrosomes often appeared misplaced from the normal axis
of division (mitotic figures). Finally, themost obvious phenotypewe
observed was that many embryos lacked nuclei in one or more large
areas (Fig. 3G). A detailed analysis of these defects revealed that
57% of Mms19::eGFP knockdown embryos (n=493) displayed
some form of cell cycle defects compared with the 14% that we
found in our control embryos (n=218; Fig. 3H). These defects were
observed most frequently between metaphase and telophase of the
cell cycle, and the defects seemed to accumulate during the later
syncytial division cycles (Fig. S5). From these experiments, we
conclude that Mms19 has important mitotic functions during the
nuclear division cycles 10-13 of the young Drosophila embryo.
Fig. 1. Third instar larval phenotype. (A-A″)Mms19P/P third instar larvae had no imaginal discs and a smaller brain. (B-B″) Imaginal discs and brains of wild-type
third instar larvae. (C-C″) Dissected third instar larvae homozygous mutant for Mms19P/P and rescued by overexpression of CAK. Most discs were rescued to
normal size, but their structural appearance was not wild type. All images are displayed at the same magnification. VNC, ventral nerve cord.
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Subcellular localization of Mms19::eGFP
We studied the localization pattern of Mms19::eGFP in young
embryos, a stage when gene products provided by the mother are
active. To ensure normal expression levels, a genomic copy of
Mms19, tagged with eGFP, was expressed maternally from its own
promoter and the endogenous Mms19 gene was inactivated
(Mms19P/P). The first 13 divisions in the Drosophila embryo are
rapid syncytial divisions that lack G phases and consist of
alternating S and M phases. Focusing again on the nuclear
division cycles 10-13, a clear Mms19::eGFP expression pattern
became apparent (Fig. 4A-E). Interphase Mms19::eGFP signal was
strongest and detected primarily in the cytoplasm whereas only a
weak signal was seen in the nuclei (Fig. 4A′,A″). Upon entry into
mitosis, the GFP signal concentrated around the nuclei with higher
signal intensity at the spindle poles. The initially low levels of
nuclear GFP signal became progressively higher during prophase
(Fig. 4B′,B″). As the nuclei entered metaphase, the signal was
present inside the nuclei where it seemed to associate with the
spindle microtubules. Additionally, small pockets free of Mms19::
eGFP signal had started to form in the cytoplasm between
neighbouring nuclei (Fig. 4C′,C″). Anaphase Mms19::eGFP signal
was still predominantly in the spindle region, but it seemed to
colocalize less with tubulin (Fig. 4D′,D″), a process that continued
into telophase (Fig. 4E′,E″). Live imaging of embryos expressing
Mms19::eGFP and Jupiter::mCherry (for marking the spindle
microtubules) gave similar results (Fig. S6) although the Mms19::
eGFP signal observed in live imaging was weaker and bleached more
readily. In the light of the various mitotic phenotypes observed in
Mms19 mutant embryos, the dynamic localization pattern of
Mms19::eGFP might point towards diverse functions of Mms19 or
towards a function that involves dynamic localization changes.
Mms19::eGFP interacts with Galla-2 and Xpd in Drosophila
embryos
Ito et al. (2010) had previously reported the existence of an MMXD
complex in human cells and they suggested that this complex might
play a role in chromosome segregation. However, the pathways
through which this complex functions still remained unknown. To
find out more about the molecular mechanisms of the mitotic
activity of Drosophila Mms19, we first tested whether fly Mms19
interacts with Xpd and Galla-2, the fly homologue of MIP18 (Yeom
et al., 2014). For this, we expressed Mms19::eGFP and performed
immunoprecipitations (IPs) with extracts from 0- to 2 h-old
Drosophila embryos. The results shown in Fig. S7A demonstrated
that pulling down Mms19::eGFP with an anti-GFP antibody led to
the specific co-IP of Xpd and Galla-2 (but not Cdk7), indicating that
these complexes are evolutionarily conserved. IPs with extracts
from HEK293T cells transfected with constructs of the three
Drosophila genes FLAG::Mms19, HA::Galla-2 and xpd confirmed
the interaction between these Drosophila proteins (Fig. S7B).
We also used these extracts to perform IPs with an antibody
against another polypeptide that forms complexes with Xpd, Cdk7.
When Cdk7 IPs were analysed for the presence of Xpd, a much
stronger Xpd signal was detected. Although IPs performed with
different antibodies cannot be compared quantitatively, the strong
difference suggests that Xpd complexes with Cdk7 are more
abundant or stable during the first 2 h of embryogenesis. It is also
possible that these complexes are present during a longer part of the
cell cycle than are complexes containingXpd andMms19 (Fig. S7A).
Importantly, these co-IPs also showed no evidence that Mms19::
eGFP and Cdk7 are present in the same complex, indicating that Xpd
interacts only with one of them at the time. Because Xpd forms
alternative complexes either with Mms19::eGFP or with Cdk7, it
appears that the binding of Xpd to Mms19 and to the Cdk7-CAK
complex might be mutually exclusive and that Mms19 and the Cdk7-
CAK complex might compete with one another for binding to Xpd.
We will discuss the structural basis for such a competition and its
implication for the regulation of the CAK activity in the Discussion.
xpd affects expression and localization of Mms19::eGFP
To test whether xpd is involved in the expression and dynamic
localization of Mms19, we studied the localization of Mms19::
eGFP in 0- to 2-h-old embryos that express little or no Xpd
maternally (xpdeE; Li et al., 2010) (Fig. 5). Indeed, in the absence of
Fig. 2. Effects of maternal Mms19 loss of function on
young embryos.Classification of different defects observed
in young embryos derived from Mms19P/P mutant germline
clones. Embryos analysed between cycles 10 and 13
exhibited severe cell cycle defects in 60% (n=260) of the
cases, but this frequency dropped to 20% (n=365) when the
mothers were also homozygous for theMms19::eGFP fusion
gene. The data shown is from three independent
experiments. Error bars represent s.d.
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XpdMms19::eGFP levels were reduced to almost half (Fig. 5G, bar
4). Consistent with the western blot result we also observed that
xpdeE embryos expressing Mms19::eGFP showed reduced GFP
staining intensity under the microscope during all stages of the cell
cycle (compare Fig. 5 with the xpd+ wild type in Fig. 4). Because
image acquisition and processing were carried out the same way for
the panels of these two figures, they can be compared directly.
Interestingly, loss of Mms19::eGFP signal in metaphase correlated
with the severity of the xpdeE phenotypes observed in individual
xpdeE embryos (compare strong phenotype in Fig. 5C with mild
defects in 5D). Although we cannot rule out the possibility that
slight differences in age distribution between the samples with and
without Xpd slightly affect the measurement of Mms19 levels (even
though embryos were collected in parallel and grown under the
same conditions) we conclude that xpd is needed for normal
Mms19::eGFP levels.
Aside from this quantitative difference, we observed that
specific aspects of the dynamic localization pattern were also
affected by the lack of Xpd. Although the interphase distribution
of Mms19::eGFP was not affected by the lack of Xpd (compare
Fig. 5A with Fig. 4A′), the specific localization of Mms19::eGFP
around the nucleus seen during wild-type prophase (Fig. 4B′)
was not observed (Fig. 5B). Whereas Mms19::eGFP usually
concentrates around the spindle during metaphase, it remained more
Fig. 3. Embryonic knockdown of Mms19::eGFP with the anti-GPF nanobody-based deGradFP technique. (A-A‴) Overlay of control embryos expressing
one copy of Mms19::eGFP and one copy of the deGradFP construct in the Mms19+/+ background. Embryos are in prophase (A), metaphase (A′), anaphase
(A″) and telophase (A‴) of cycle 12. (B-G) Embryos with reduced Mms19::eGFP (B,C,E-G) and control embryos for comparison (D). (B) Chromosomal
bridges formed as a result of chromosome segregation failure during telophase of a cycle 12. (C) Elongated metaphase spindles in a cycle 10 embryo. Elongated
spindles range from 15 to 19 µm in length. The presented one is 16.97 µm long. (D) Metaphase spindles in cycle 10 of control embryos range from 12 to 14 µm.
(E) Spindle defects such as formation of multipolar spindles and spindle crossovers are indicated by arrowheads. (F) Kinked axis of division of nuclei in
mutant embryo during telophase (indicated by arrowheads). (G) Large numbers of missing nuclei in a mutant cycle 12 embryo. (H) Comparison of different cell
cycle defects between control (n=218) and Mms19::eGFP knockdown embryos (n=493). All defects became visible during the mitotic phase of the cell cycle,
when 57% of Mms19::eGFP knockdown embryos have one or more of the defects. Scale bars: 20 μm. Error bars represent s.d.
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uniformly cytoplasmic in embryos lackingXpd (compare Fig. 5Dwith
Fig. 4C′). Similarly, the staining adjacent to centrosomes observed in
wild-type telophases was lost in xpdeE embryos and, instead, the
cytoplasmic signal seemed more uniform (Fig. 5F). We conclude that
xpd plays a role in localizing Mms19::eGFP around the nuclear
envelope in prophase, in the spindle region in metaphase and around
the centrosomes in telophase.
To find out whether Xpd levels also depend on Mms19 activity,
we usedMms19P/P germline mutant embryos to measure Xpd levels
relative to α-Tubulin levels in the same sample. Indeed, western
blotting revealed a significant reduction of Xpd levels inMms19P/P
germline mutant embryos (Fig. 5H). Therefore, Mms19 and Xpd
mutually depend on each other for their normal expression and
stability.
Overexpression of CAK restores the diploid larval tissue in
Mms19P/Pmutants
Lack of diploid tissues similar to our observations in Mms19P/P
larvae has also been described for Cdk7 and Cdk1 loss-of-function
mutants (Larochelle et al., 1998; Stern et al., 1993). This similarity
suggests that Mms19 might be acting through the Cdk7-Cdk1
pathway to perform its role in mitosis, even though it did not seem to
physically interact with Cdk7 (Fig. S6A). If true, it might be
possible to rescue the Mms19 mutant phenotype partially by
overexpressing the CAK complex. To test this pathway, we
overexpressed Cdk7, Cyclin H and Mat1 under the control of the
daughterless (da)-Gal4 driver in Mms19P/P larvae. Amazingly,
overexpression of CAK was able to bring back all imaginal discs
(Fig. 1C-C″). Even though at least some discs appeared less well-
structured than their wild-type counterparts, they reached the
normal size. In contrast, Mms19P/P larvae did not show any disc
formation even 14 days after egg laying when they had reached the
size of wild-type third instar larvae (Fig. 1A-A″).
Xpd has been shown to repress the CAK activity of Cdk7 (Chen
et al., 2003). To understand better the role of the interactions
between Mms19 and Xpd, we considered the possibility that
Mms19 not only activates or stabilizes Xpd by delivering the Fe-S
cluster (Gari et al., 2012; Stehling et al., 2012), but that Mms19
might also prevent Xpd from inhibiting the CAK activity during
normal mitosis. If this is true, it might be possible to also rescue the
Mms19 mutant phenotype partially by downregulating xpd in the
Mms19P/P background. We tested this hypothesis with two different
approaches. First, we reduced xpd activity preferentially in the
diploid tissue by driving xpd RNAi with the da-Gal4 driver. This
treatment did not increase larval viability, possibly because the
knockdown was so severe that lack of Xpd killed the larvae.
Replacing the wild-type xpd+ chromosome with either of two
unrelated chromosomes carrying an xpd− loss-of-function mutation
(xpdP and a deficiency for xpd) we obtained partial rescue of most of
the embryonic phenotypes of Mms19P/P germline clones, strongly
suggesting that reducing the xpd+ dose causes suppression of the
Mms19 phenotypes. Overall, suppression caused the frequency of
mitotic phenotypes in embryos in division cycles 10-13 to drop
from 60% to 30% (Fig. 6). Interestingly, although most of the
different phenotypes were rescued, the frequency of the phenotype
‘chromosome segregation defects’ actually increased in the
presence of only one functional xpd+ copy (Fig. 6).
DISCUSSION
Human and yeast MMS19 are part of the late-acting CIA machinery
that facilitates the transfer of Fe-S clusters to their target proteins
(Gari et al., 2012; Stehling et al., 2012). Human MMS19 performs
this activity as part of a cytoplasmic complex with the other
components of the CIA machinery, CIAO1, MIP18 and IPO1. The
targets of this machinery are Fe-S cluster-binding proteins that
interact with DNA and have functions in DNA repair. One
additional MMS19 study described a potentially unrelated role for
MMS19 and MIP18 in mitosis because siRNA-mediated
knockdown of MMS19 or MIP18 led to mitotic defects (Ito et al.,
2010). Similarly, reducing the activity of the fly genes encoding the
two Mip18 homologues Galla-1 and Galla-2 also led to mitotic
phenotypes, suggesting that the mitotic function of Mms19 is
performed by the Mms19/Mip18 complex and that this function is
conserved from flies to humans (Yeom et al., 2014). These studies
combined led to the interesting question of whether the effects on
chromosome segregation and spindle dynamics observed upon
MMS19 knockdown in human cells are an indirect result of its role
Fig. 4. Mms19::eGFP distribution during the embryonic cell cycle.
Confocal settings were adjusted such that no signal was apparent in the GFP
channel when imaging wild-type control embryos lacking GFP (wild-type
embryo, A-E). The same microscope settings were then used to image
embryos expressing Mms19::eGFP. (A′,A″) Cycle 10 embryo during
interphase. (B′,B″) Prophase cycle 11 embryo, showing localization of
Mms19::eGFP around the nuclei and also inside them. (C′,C″) Spindle
microtubule and nuclear localization of Mms19::eGFP during metaphase 11.
(D′,D″) Anaphase 12 embryo. (E′,E″) Cycle 12 embryo in telophase showing
the presence of Mms19::eGFP in nuclei and in mid bodies. In merge panels,
DNA is in blue, α-Tubulin in red, Mms19::eGFP in green. Scale bars: 20 µm.
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in the CIA or whether they point to a more direct role of Mms19 in
mitosis.
The function of MMS19 had so far not been studied in
multicellular organisms and this study on Drosophila Mms19
therefore describes for the first time the essential role ofMms19 as a
mitotic gene. It has this role in cells with different types of cell
cycles – the rapid cycles in syncytial embryos, which lack G phases,
and diploid larval cells, which show a full cell cycle with G phases.
At the organismal level, lack ofMms19 causes lethality at the larval-
to-pupal transition and it results in reduced brain size and in the
absence of imaginal discs and other diploid cells (Fig. 1A-A″), a
phenotype that has long been considered typical for mitotic genes
Fig. 5. Mislocalization of Mms19::eGFP in xpdeE embryos. Compared with the expression of Mms19::eGFP in wild-type embryos (Fig. 4), the expression
in xpdeE embryos is reduced as is evident from the weaker GFP signal in all phases of the cell cycle. Antibody staining was performed in parallel and
settings for imaging were identical. (A,A′) During interphase, the weaker Mms19::eGFP signal was normally distributed. (B,B′) During prophase, the stronger
Mms19::eGFP signal around the nuclei was missing/absent, but the protein was still present primarily in the cytoplasm. (C,C′) Embryo with severe defects
showing very little Mms19::eGFP expression and no specific localization. (D,D′) In metaphase embryos with mild defects, the Mms19::eGFP expression was not
very different from that of the wild type and it localized also to the spindle microtubules. (E-F′) Anaphase (E,E′) and telophase (F,F′) embryos showed
reduced Mms19::eGFP expression with loss of specific localization at the spindle microtubules and around the nuclei, respectively. In merge panels, DNA is
shown in blue, α-Tubulin in red. (G) Expression of Mms19::eGFP protein was normalized to α-Tubulin. Mms19::eGFP protein levels are reduced to almost half
upon knockdown with the deGradFP technique (2, star) compared with controls without knockdown (1, 3) expression. Similarly, reduced Mms19::eGFP
levels were also observed in xpdeE embryos (4, sun). (H) Quantification of Xpd protein levels relative to α-Tubulin in the same sample of embryos derived from
mothers with the indicated genotype. Xpd levels are strongly reduced in xpdeE embryos (2, star) and normalized Xpd levels were also reduced in embryos derived
from Mms19P/P mutant germline clones (3, sun). In G,H, results were from three independent experiments and error bars represent s.d. Scale bars: 20 µm.
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(Gatti andBaker, 1989; Larochelle et al., 1998; Stern et al., 1993).We
were also able to demonstrate directly the mitotic function ofMms19
by knocking down the Mms19 protein supplied to the zygote by the
mother. Reducing Mms19 proteins in young embryos led to several
severe mitotic defects in syncytial embryos (Fig. 3).
The subcellular localization of Mms19::eGFP is highly dynamic
during the syncytial division cycles (Fig. 4). Mms19::eGFP is
localized to the cytoplasm during interphase and previous studies
showed that this is where it interacts with the CIA machinery and
transfers the Fe-S cluster to target proteins, such as XPD (Gari et al.,
2012; Vashisht et al., 2015). During M phase, Mms19::eGFP then
enters the nuclear area and it can be observed in the vicinity of the
spindle microtubules. Given its mitotic functions and the defects in
spindle structure and dynamics observed when Mms19 activity is
reduced, the mitotic localization around the spindle region might be
the place where it plays a CIA-independent role in mitosis. In this
context, it is also interesting to note that independent studies have
found Mms19 associated with Tubulin in extracts from young
Drosophila embryos (Gallaud et al., 2014).
The mitotic function of Mms19 and Galla-2/MIP18 combined
with the fact that Drosophila and human Mms19 form complexes
with Xpd and Galla-2/MIP18 is intriguing because Xpd regulates
mitosis through Cdk-activating kinase (CAK) (Chen et al., 2003; Li
et al., 2010; Ito et al., 2010; Yeom et al., 2014). We therefore
considered the possibility that Mms19 could act through the same
pathway as Xpd and CAK to allow cell cycle progression through
mitosis. The fact that lack of Cdk7 (Larochelle et al., 1998) or Cdk1
(Stern et al., 1993) function causes the same larval phenotype as
lack of Mms19 further supports this view. This suggests that the
major function of Mms19 in mitosis could be to allow CAK to
phosphorylate and strongly activate the mitotic kinase Cdk1. We
were able to confirm this hypothesis by overexpressing the
components of the trimeric CAK complex with the da-Gal4
driver inMms19P/Pmutant larvae. This led to remarkable restoration
of imaginal disc formation (Fig. 1C-C″) and suggests that the excess
CAK is capable of activating the mitotic Cdk1 in the absence of
Mms19. From this, we conclude that an important function of
Mms19 is to activate the mitotic kinases or kinase pathways and that
the Mms19 mutant phenotypes, the mitotic defects observed in
syncytial embryos and in larval cells, are caused by incomplete
activation of the mitotic kinase pathway.
What role could the interaction between Mms19 and Xpd play in
mitotic progression? Xpd is able to prevent CAK from activating
Cdk1 and there is evidence that Xpd can get redistributed or
downregulated at the beginning of mitosis (Chen and Suter, 2003;
Chen et al., 2003). Mms19 could therefore act as a regulator of Xpd
and prevent it from inactivating the Cdk-activating kinase activity of
the trimeric Cdk7/CycH/Mat1 (CAK) complex as cells enter
mitosis. The proposed pathway predicts that it might be possible
to rescue the Mms19 mutant phenotype not only by overexpression
of CAK, but possibly also by reducing the Xpd levels in Mms19
mutants. Indeed, most of the defects observed in young embryos
lacking functional Mms19 could be partially rescued by exchanging
one wild-type xpd+ chromosome with either of two unrelated
chromosomes that are xpd−. The fact that two unrelated xpd−
chromosomes cause this suppression strongly suggests that it is indeed
the reduction of the xpd dose that causes the suppression and not
another mutation that happens to be present on both chromosomes.
We therefore found good evidence that the suppression is indeed
caused by the reduction of functional xpd. Based on these results, we
propose a pathway for the mitotic function of Mms19. As cells enter
mitosis, Mms19 prevents Xpd from inhibiting the Cdk-activating
kinase activity of the CAK complex. The fully active CAK then
performs its function during the cell cycle and phosphorylates Cdk1 in
its T-loop, an essential step in the activation of Cdk1.
Although the overexpression of the three CAK components can
rescue imaginal disc formation, leading to outgrown discs, the
structure of the discs appeared abnormal under the light microscope.
Interestingly, suppression was possible with the da-Gal4 driver, but
not with actin-Gal4 or 6985-Gal4. This points to the importance of
the amount, tissue specificity and timing of CAK expression for the
division of these diploid cells. Aside from proper fine-tuning of
CAK activity, lack of the cytoplasmic function of Mms19 in
activating and stabilizing Xpd and other Fe-S-containing proteins
(Gari et al., 2012; Stehling et al., 2012; Vashisht et al., 2015) might
also contribute to the defects still observed in the rescued discs.
A recently published article could provide the structural basis for
the dual role of Mms19 towards Xpd that we are proposing. There is
good evidence that Fe-S cluster proteins receive the Fe-S cluster by
binding to the C terminus of MMS19 (Odermatt and Gari, 2017).
Stable interaction with the C terminus also requires the other CIA
proteins, MIP18 and CIAO1. Although it is not yet clear whether
Xpd binds the C terminus of MMS19, Xpd was shown to bind
strongly to the N terminus of MMS19, even in the absence of other
CIA proteins. It will be interesting and important to find out whether
two different binding sites are used for the two different functions.
Previous studies found that the interaction of XPD with MMS19
and with core TFIIH components are mutually exclusive (Ito et al.,
2010; Vashisht et al., 2015). Similarly, we also found that the
interactions of Drosophila Xpd with the Cdk7-CAK complex and
with Mms19::eGFP are mutually exclusive (Fig. S7A). It thus
Fig. 6. Reducing the xpd dose can rescue the Mms19 phenotype. Of the
different mitotic phenotypes observed in embryos that do not obtain functional
Mms19 from their mothers, all but one can be rescued at least partially by
reducing the xpd+ dose using heterozygous xpd−/+ loss-of-function
chromosomes. Two independent xpd− chromosomes were used: xpdP and
Df(xpd), a chromosome that has the xpd gene deleted. The exceptions were
the chromosome segregation defects, which increased under these
conditions. Overall, embryos derived from Mms19P/P germline clones
containing two copies of xpd+ showed mitotic phenotypes in 60% (n=260) of
cycle 10-13 embryos, whereas embryos derived from Mms19P/P germline
clones with only one copy of xpd+ showed such phenotypes only in 30%
(n=260) of cycle 10-13 embryos with the xpdP chromosome and 26.8%
(n=317) with the Df(xpd) chromosome. Results were obtained from three
independent experiments. Error bars show represent s.d.
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appears that Mms19 binding to Xpd competes with the interaction
of Xpd with the core TFIIH component p44 and the CAK complex.
Our model therefore proposes that Mms19 binding releases Xpd
from core TFIIH by releasing it from p44 and that it additionally
releases the trimeric CAK complex fromXpd, allowing it to become
an active Cdk-activating kinase. Interestingly, the regions on Xpd
needed for the binding of the three different proteins have been
mapped and they seem to explain such a competition model
(summarized by Stettler et al., 2014). The region in XPD spanning
amino acids 277-286 is essential for its interaction with MMS19
(Vashisht et al., 2015) and it is part of the ARCH domain (amino
acids 245-443), which is also required for its stable association with
the trimeric CAK complex (Sandrock and Egly, 2001). Similarly,
the binding sites for Mms19 and p44 are at least adjacent if not
overlapping (Sandrock and Egly, 2001; Dubaele et al., 2003;
Stettler et al., 2014). Steric interference and direct competition for
binding sites might therefore provide the structural basis for the
exclusive interaction of XPD with either Mms19 or the CAK (and
TFIIH) complex. This mechanism could allow Mms19 to sequester
Xpd from the CAK complex during mitosis.
Our model describes how the Mms19-Xpd interaction causes
fluctuations of cellular CAK activity. This mechanism might
spatially and temporally regulate the rapid nuclear division cycles of
the embryo. Edgar and co-workers have carefully analysed the
different modes of regulation of Cdk1 activity during the early
embryonic cycles of Drosophila development and they found that
only two Cdk1 isoforms are present during the first 13 cycles.
Whereas the inhibitory phosphorylations at the N terminus, known
to control Cdk1 activity in later embryonic stages, are not detectable
during these early division cycles, the non-phosphorylated isoform
and the T-loop phosphorylated isoform, which has become
phosphorylated and activated by CAK, are present (Edgar et al.,
1994). During the first eight nuclear cycles, fluctuations of the ratio
of these two isoforms are not apparent on western blots, but local
fluctuations might still happen. However, from cycle 9 onwards
such changes could be demonstrated using carefully staged
embryos. From this stage onwards, cell cycle phase-dependent
differences become progressively more pronounced with the T-loop
phosphorylated isoform being more abundant during M phase and
reduced during interphase. By cycle 13, the interphase reduction
was so strong that this isoform was barely detectable (Edgar et al.,
1994). This developmental window, in which the fluctuation of
Cdk1 T-loop phosphorylation becomes progressively stronger,
coincides with the window in which zygotic transcription increases
progressively, too (reviewed by Lee et al., 2014; Tadros and
Lipshitz, 2009). So far, the mechanism for this cell cycle phase-
dependent change in Cdk1 activation has remained unknown. Our
model can explain these observations and it requires neither
synthesis nor degradation of regulatory proteins. Once Xpd binds to
CAK in interphase, it would recruit CAK into TFIIH for the
transcription activity and at the expense of its Cdk1-activating
activity (Li et al., 2010; Fisher et al., 2012). Once Mms19 binds to
Xpd, the trimeric CAK complex would be released from Xpd and
TFIIH, shutting down transcription, but enabling freed CAK to
phosphorylate the Cdk1 T-loop and activate the M-phase kinase
during the M phase.
MATERIALS AND METHODS
DNA constructs and transgenic flies
For theMms19::eGFP construct, theMms19 gene region along with 432 bp
of 5′ and 372 bp of 3′ flanking sequences were amplified from genomic fly
DNA of the OregonR fly strain. The eGFP open reading frame (ORF) was
amplified from a plasmid (Heim et al., 1995). The sequences were cloned
into the pw+SNattB vector (Koch et al., 2009) with the eGFPORF at the C-
terminal end of theMms19ORF.The constructs for overexpressing the CAK
complex were obtained by individually cloning the coding sequences of
Cdk7, Mat1 and Cyclin H amplified from fly cDNA in the pUAST-attB
vector (Bischof et al., 2007). Transgenic stocks were established with the
attP landing platform 58A (forMms19::eGFP), 22A3 (forCdk7), 65B2 (for
Mat1), 86F8 (for Cyclin H) and theΦC31 integration system (Bischof et al.,
2007). DNA constructs used for transfection into HEK293T cells were made
by cloning the ORF of fly Mms19, Galla-2 and xpd from OregonR cDNAs
into the pCS2 vector (Addgene).
Fly stocks
The following fly lines were obtained from the Bloomington Stock Center:
y1 w*; P{neoFRT}82B Sb1/TM6(#2051),w*; P{neoFRT}82B P{ovoD1-
18}3R/ st1 βTub85DD ss1 es/TM3, Sb1 (#2149),da-GAL4 (#55851), y1
w67c23; P{EPgy2}Mms19EY00797/TM3, Sb1 Ser1 (#15477; referred to as
Mms19P), w;Df(3R)ED5147/TM6C, Sb (#8967 Mms19 deficiency line in
which 82E7-83A1 is deleted). xpdeE embryos were obtained as described
previously (Li et al., 2010).
Immunostaining and image analysis
Embryo staining was described previously (Chen et al., 2003). Primary
antibodies used for staining were: rabbit anti-CNN (1:500; Heuer et al.,
1995), rabbit anti-GFP (1:300; 210-PS-1GFP, ImmunoKontact; pre-
absorbed before use) and mouse anti-α-Tubulin, clone DM1A (1:500;
T9026, Sigma). DNA was visualized with 2.5 µg/ml Hoechst 33258
(Molecular Probes). The secondary antibodies were anti-rabbit and
anti-mouse Oregon Green 488 and Alexa Fluor 594 (1:1000; O-11038
and A-11032, Molecular Probes). All imaging of fixed samples was
performed using Leica TCS-SP8 confocal microscopes. The images were
analysed using Fiji software. For embryos stained with anti-GFP antibody,
the background was removed by setting minimal pixel value to 50 and the
maximal one to 255. This was done for both control embryos and embryos
expressing Mms19::eGFP.
Live imaging
Flies for live imaging were maintained at 25°C and allowed to lay eggs on
apple juice plates for 3 h before collection started. Embryos were then
dechorionated with 2.5% bleach, washed well with water, glued to the
coverslip using heptane glue and then covered with Voltalef oil 3S (VWR).
Live imaging was performed with a Leica TCS-SP8 confocal microscope in
a chamber maintained at 25°C. The images were then z-projected and de-
noised using Fiji.
Culturing and transfection of HEK293T cells
The HEK293T cells were maintained in culture at 37°C in 75 cm2 flasks
using DMEM medium with 10% foetal calf serum. Transfections were
carried out 15 h after seeding (∼70% confluent) using polyethylenimine
(PEI). The ratio of PEI to DNA was 1:3. Cells were harvested 48 h after
transfection.
Immunoprecipitation and western blotting
For immunoprecipitation with embryo extract, 1 g of embryos per sample
was homogenized in 1 ml lysis buffer [25 mM HEPES pH 7.4, 150 mM
NaCl, 0.5 mM EDTA pH8.0, 1× protease inhibitor cocktail (Roche), 1×
phosphatase inhibitors, 0.5% NP-40, 2 mM MgCl2, 2 mM dithiothreitol].
The lysate was incubated at 4°C for 6 h with proteinG beads (GE
Healthcare), pre-coated with monoclonal anti-GFP antibody (gift from
Anne Marcil, National Research Council, Montréal, Canada; 1:300). The
beads were washed three times in lysis buffer before the protein was eluted
in Lämmli buffer. Immunoprecipitation experiments with HEK293T cells
were carried out 48 h after transfection. The lysis buffer used for cells
contained 20 mM Tris pH 7.4, 150 mMNaCl, 2 mM EDTA pH 8.0, 50 mM
NaF, 10% glycerol, 1% Triton X-100, 1× protease inhibitor cocktail (Roche)
and 100 mM phenylmethylsulphonyl fluoride. The supernatant was then
incubated overnight with proteinG beads (GE Healthcare), pre-coated with
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rat anti-HA antibody (Roche). Proteins eluted in Lämmli buffer were then
run on SDS-PAGE gels for detection. Primary antibodies used for western
blot detection were: rabbit anti-GFP (1:1000; 210-PS-1GFP,
ImmunoKontact), rat anti-HA (1:1000; 11867423001, Roche), rabbit anti-
FLAG (1:1000; SC.807, Santa Cruz), rabbit anti-Xpd (1:500; Chen et al.,
2003), monoclonal anti-alpha-Tubulin (1:1000; AA4.3, Developmental
Studies Hybridoma Bank), rabbit anti-Galla-2 (1:5000; Yeom et al., 2014),
monoclonal anti-Cdk7 (1:20; Larochelle et al., 1998), rabbit anti-
pCdk1(Thr161) (1:1000; 9114, Cell Signaling Technologies) and rabbit
anti-Cdk1(PSTAIRE) (1:1000; 06-923, Sigma/Merck). Secondary
antibodies used were horseradish peroxidase-conjugated antibodies
(1:10,000; NA934V, NA931V, NA935V, GE Healthcare). The blots were
analysed using Fiji software.
For western blots with pCdk1 antibodies, diploid tissues from 50 third
instar larvae were used per sample. The samples were homogenized in
Lämmli buffer containing protease inhibitors and phosphatase inhibitors.
The SDS-PAGE gels used to resolve the samples were prepared with 30%
T:1.67% C acrylamide stock solution using piperazine di acrylamide
(BioRad) as the cross linker to resolve better the phosphorylated isoforms of
Cdk1 (Larochelle and Fisher, 2005).
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Suter, B. (2014). A Drosophila XPDmodel links cell cycle coordination with neuro-
development and suggests links to cancer. Dis. Model. Mech. 8, 81-91.
Tadros, W. and Lipshitz, H. D. (2009). The maternal-to-zygotic transition: a play in
two acts. Development 136, 3033-3042.
Vashisht, A. A., Yu, C. C., Sharma, T., Ro, K. andWohlschlegel, J. A. (2015). The
association of the xeroderma pigmentosum group D DNA helicase (XPD) with
transcription factor IIH is regulated by the cytosolic iron-sulfur cluster assembly
pathway. J. Biol. Chem. 290, 14218-14225.
Yeom, E., Hong, S.-T. and Choi, K.-W. (2014). Crumbs interacts with Xpd for
nuclear division control in Drosophila. Oncogene 34, 2777-2789.
10
RESEARCH ARTICLE Development (2018) 145, dev156802. doi:10.1242/dev.156802
D
E
V
E
LO
P
M
E
N
T
